Publication | Closed Access

Mycophenolate mofetil monotherapy: an example of a safe nephrotoxicity/atherogenicity-free immunosuppressive maintenance regimen in a selected group of kidney-transplanted patients

UrologyTransplantationKidney-transplanted PatientsKidney TransplantMedicineKidney TransplantationSolid Organ TransplantationImmunosuppressive TherapyMycophenolate Mofetil MonotherapyChronic Kidney DiseaseNephrology